Non-steroidal anti-inflammatory medicine (NSAIDs) are a gaggle of medicine that are extensively used globally for the remedy of ache and irritation, and within the case of aspirin, for secondary prevention of heart problems. Chronic non-steroidal anti-inflammatory drug use is related to probably critical higher gastrointestinal opposed drug reactions (ADRs) together with peptic ulcer illness and gastrointestinal bleeding.
A number of scientific and genetic predisposing components have been recognized; nonetheless, genetic knowledge are contradictory. Further analysis is required to determine clinically related genetic and non-genetic markers predisposing to NSAID-induced peptic ulceration.
Is Perceived Athlete Leadership Quality Related to Inside Sacrifice and Perceived Performance in Team Sports? The Mediating Role of Team Identification
The research aimed to research the connection between athletes’ perceptions of athlete management high quality, staff identification, inside sacrifice, and efficiency. A complete of 299 gamers of collective sports activities (soccer, seaside soccer, basketball, volleyball; M age 19.05, SD = 5.10) participated via a cross-sectional design survey.
Data had been analyze
d utilizing structural equation modeling. Results spotlight the optimistic relationships between perceived high quality of athlete leaders, inside sacrifice, and perceived efficiency, and between inside sacrifice and perceived efficiency. Furthermore, inside sacrifice perceived by the athletes was a optimistic mediator between perceived athlete management high quality and perceived efficiency.
Also, staff identification was a optimistic mediator within the affiliation between inside sacrifice and perceived efficiency. These findings lengthen information concerning the athlete management high quality context. These outcomes can be helpful for additional analysis and implications in staff sports activities’ efficiency, as coaches and sports activities psychologists would have extra details about their groups’ perceptions of management high quality to attain optimistic outcomes in gamers’ inside sacrifice and efficiency. The findings additionally spotlight the significance of creating staff identification to enhance the relationships between perceived athlete management high quality, inside sacrifice, and perceived efficiency.
The Combined Effect of Safety Specific Transformational Leadership and Safety Consciousness on Psychological Well-Being of Healthcare Workers
Occupational well being analysisers have begun to understand that the psychological well-being of healthcare staff who’re offering remedy in opposition to COVID-19 is deteriorating. However, there’s minimal analysis performed on it, significantly within the context of management. The present research goals to fill this vital hole by figuring out crucial components that may improve the psychological well-being of healthcare staff.
We proposed that security particular transformational management enhances psychological well-being amongst healthcare staff, and COVID-19 perceived threat mediates this relationship. Furthermore, the protection conscientiousness of healthcare staff was proposed to be a boundary situation that enhances the destructive relationship between safety-specific transformational management and COVID-19 perceived threat.
Data had been collected from healthcare staff (N = 232) treating COVID-19 sufferers within the hospitals of Pakistan via well-established adopted questionnaires. The discriminant and convergent validity of the knowledge was examined via confirmatory issue evaluation by utilizing AMOS statistical bundle. The mediation and moderation hypotheses had been examined by utilizing PROCESS Macro by Hayes.
The outcomes confirmed that security particular transformational management enhances psychological well-being amongst healthcare staff, and COVID-19 perceived threat mediates this relationship. Moderation outcomes additionally confirmed that security conscientiousness moderates the connection between security particular transformational management and COVID-19 perceived threat. This research provides implications for each analysisers and practitioners.
Coating matching advice based mostly on improved fuzzy complete analysis and collaborative filtering algorithm
Coating matching design is one of the vital elements of ship coating course of design. The choice of coating matching is influenced by numerous components similar to marine corrosive setting, anti-corrosion interval and dealing circumstances. There are additionally variations within the coating efficiency necessities for various ship sorts and completely different coating elem
ents.
At current, the design of coating matching in shipyards is determined by the expertise of technologist, which isn’t conducive to the scientific administration of ship portray course of and the macro management of ship development price. Therefore, this paper proposes a hybrid algorithm of fuzzy complete analysis and collaborative filtering based mostly on consumer label enchancment (IFCE-CF).
Based on the analytic hierarchy course of (AHP), the analysis index system of coating matching is constructed, and the load calculation course of of fuzzy complete analysis is optimized by introducing the consumer label weight. The collaborative filtering algorithm based mostly on matrix decomposition is used to understand the correct advice of coating matching.
Historical coating course of knowledge of a shipyard between 2010 and 2020 are chosen to confirm the advice potential of the strategy within the paper. The outcomes present that utilizing the coating matching clever advice algorithm proposed on this paper, the basis imply sq. error is < 1.02 and the imply absolute error is < 0.75, the prediction accuracy is considerably higher than different analysis strategies, which proves the effectiveness of the strategy.
Measuring Youth Empowerment: An Item Response Theory Analysis of the Sociopolitical Control Scale for Youth
Sociopolitical management (SPC) has been recognized as a key ingredient of the intrapersonal element of psychological empowerment. The Sociopolitical Control Scale (SPCS) is a extensively used measure and has been modified to be used amongst youth (SPCS-Y). In gentle of the rising curiosity in SPC amongst youth inside community-based analysis, this research utilized merchandise response principle (IRT) to look at the psychometric properties of the SPCS-Y and to discover a quick model.
Data had been collected between 2006 and 2013 from a comfort pattern of highschool college students (N = 1,808), situated in a midsized, economically deprived city neighborhood within the northeastern United States. Findings point out that the 2 subscales, management competence, and coverage management, had been unidimensional and gadgets functioned properly.
) Anti-CD40 antibody (Alexa-fluor 488) |
|
STJ170000 |
St John's Laboratory |
100 µg |
EUR 393 |
|
Description: CD40 (48 to 50 kDa) is a transmembrane glycoprotein mainly expressed on the surface of B cells and also expressed on monocytes, dendritic cells, and thymic epithelium. CD40 is a member of the tumor necrosis factor (TNF) receptor superfamily, which includes the low affinity nerve growth factor (NGF) receptor and CD95/Fas. CD40 is the receptor for CD40 ligand. CD40L (CD40L, CD154, gp39, and TRAM) belongs to the TNF gene family and is expressed more widely than CD40, predominantly on activated CD4+ T cells. Following interaction with CD40 ligand, CD40 mediates a number of major immunoregulatory functions, central to the control of thymus dependent humoral immunity and may be critical in the development of cell mediated immune responses. Other biological actions include B cell homotypic adhesion, proliferation, immunoglobulin isotype switch, and secretion. Activation of CD40 has also been shown to inhibit the growth of certain B cell lymphomas and to induce the death of transformed cells of mesenchymal or epithelial origin |
) Anti-LAMP3 antibody (Alexa-fluor 488) |
|
STJ170004 |
St John's Laboratory |
100 µg |
EUR 393 |
|
Description: The dendritic cell lysosomal-associated membrane protein (DC-LAMP)/CD208 is a type I integral transmembrane glycoprotein mostly homologous to CD68, of about 45 kDa in mouse and 90 kDa in human (glycosylation), with a bipartite C-terminal structure divided by a serine/proline rich region, a transmembrane domain and a conserved tyrosine-based lysosomal targeting motif in its cytoplasmic tail. Initially cloned as a specific marker of human mature dendritic cells (DCs), DC-LAMP has been subsequently shown to be expressed in alveolar type II pneumocytes. In both cell types, the molecule is found in the limiting membrane of intracellular multi-lamellar bodies, known as MIIC (MHC class II compartments) in human mature DCs and as lung surfactant-containing lamellar bodies in type II pneumocytes. In the latter cell type, DC-LAMP expression is also detected at the cell surface. |
) Anti-LAMP3 antibody (Alexa-fluor 546) |
|
STJ170005 |
St John's Laboratory |
100 µg |
EUR 393 |
|
Description: The dendritic cell lysosomal-associated membrane protein (DC-LAMP)/CD208 is a type I integral transmembrane glycoprotein mostly homologous to CD68, of about 45 kDa in mouse and 90 kDa in human (glycosylation), with a bipartite C-terminal structure divided by a serine/proline rich region, a transmembrane domain and a conserved tyrosine-based lysosomal targeting motif in its cytoplasmic tail. Initially cloned as a specific marker of human mature dendritic cells (DCs), DC-LAMP has been subsequently shown to be expressed in alveolar type II pneumocytes. In both cell types, the molecule is found in the limiting membrane of intracellular multi-lamellar bodies, known as MIIC (MHC class II compartments) in human mature DCs and as lung surfactant-containing lamellar bodies in type II pneumocytes. In the latter cell type, DC-LAMP expression is also detected at the cell surface. |
) Anti-LAMP3 antibody (Alexa-fluor 647) |
|
STJ170006 |
St John's Laboratory |
100 µg |
EUR 393 |
|
Description: The dendritic cell lysosomal-associated membrane protein (DC-LAMP)/CD208 is a type I integral transmembrane glycoprotein mostly homologous to CD68, of about 45 kDa in mouse and 90 kDa in human (glycosylation), with a bipartite C-terminal structure divided by a serine/proline rich region, a transmembrane domain and a conserved tyrosine-based lysosomal targeting motif in its cytoplasmic tail. Initially cloned as a specific marker of human mature dendritic cells (DCs), DC-LAMP has been subsequently shown to be expressed in alveolar type II pneumocytes. In both cell types, the molecule is found in the limiting membrane of intracellular multi-lamellar bodies, known as MIIC (MHC class II compartments) in human mature DCs and as lung surfactant-containing lamellar bodies in type II pneumocytes. In the latter cell type, DC-LAMP expression is also detected at the cell surface. |
) Anti-IL3RA antibody (Alexa-fluor 488) |
|
STJ170009 |
St John's Laboratory |
100 µg |
EUR 393 |
|
Description: IL3 exerts its biologic activity through its interaction with a cell surface receptor that consists of two subunits. The a subunit (CD123) specifically binds IL3, whereas the ß subunit is required for signaling and is common to the GMCSFR and IL5-R. 107D2.08 and 106C2.02 mAbs were obtained after mouse immunization with sorted human tonsillar PDC. Both clones strongly stain PDCs and basophils, weakly stain monocytes, CD34+ derived DCs and CD11c+ DC, while no staining is observed on T, B, NK cells as well as on mono-derived DCs. Staining with 107D2.08 and 106C2.02 mAbs are maintained on sorted PDC cultured in the presence of IL3 and CD40L, but lost when IL3 alone is added to the culture. The recognition of the IL3Ra chain by 107D2.08 and 106C2.02 was confirmed by transfection studies. 107D2.08 appeared to be the most appropriate clone for in situ studies. 107D2.08 allowed the first observation of IL3Ra+ cells in breast tumor microenvironment |
) Anti-IL3RA antibody (Alexa-fluor 546) |
|
STJ170010 |
St John's Laboratory |
100 µg |
EUR 393 |
|
Description: IL3 exerts its biologic activity through its interaction with a cell surface receptor that consists of two subunits. The a subunit (CD123) specifically binds IL3, whereas the ß subunit is required for signaling and is common to the GMCSFR and IL5-R. 107D2.08 and 106C2.02 mAbs were obtained after mouse immunization with sorted human tonsillar PDC. Both clones strongly stain PDCs and basophils, weakly stain monocytes, CD34+ derived DCs and CD11c+ DC, while no staining is observed on T, B, NK cells as well as on mono-derived DCs. Staining with 107D2.08 and 106C2.02 mAbs are maintained on sorted PDC cultured in the presence of IL3 and CD40L, but lost when IL3 alone is added to the culture. The recognition of the IL3Ra chain by 107D2.08 and 106C2.02 was confirmed by transfection studies. 107D2.08 appeared to be the most appropriate clone for in situ studies. 107D2.08 allowed the first observation of IL3Ra+ cells in breast tumor microenvironment |
) Anti-IL3RA antibody (Alexa-fluor 647) |
|
STJ170011 |
St John's Laboratory |
100 µg |
EUR 393 |
|
Description: IL3 exerts its biologic activity through its interaction with a cell surface receptor that consists of two subunits. The a subunit (CD123) specifically binds IL3, whereas the ß subunit is required for signaling and is common to the GMCSFR and IL5-R. 107D2.08 and 106C2.02 mAbs were obtained after mouse immunization with sorted human tonsillar PDC. Both clones strongly stain PDCs and basophils, weakly stain monocytes, CD34+ derived DCs and CD11c+ DC, while no staining is observed on T, B, NK cells as well as on mono-derived DCs. Staining with 107D2.08 and 106C2.02 mAbs are maintained on sorted PDC cultured in the presence of IL3 and CD40L, but lost when IL3 alone is added to the culture. The recognition of the IL3Ra chain by 107D2.08 and 106C2.02 was confirmed by transfection studies. 107D2.08 appeared to be the most appropriate clone for in situ studies. 107D2.08 allowed the first observation of IL3Ra+ cells in breast tumor microenvironment |
) Anti-CD207 antibody (Alexa-fluor 488) |
|
STJ170014 |
St John's Laboratory |
100 µg |
EUR 393 |
|
Description: Langerin/CD207 is a transmembrane C-type lectin receptor (CLR) of epidermal and mucosal Langerhans cells (LCs) that induces Birbeck's granule formation. Langerin features a single carbohydrate recognition domain (CRD) with mannose-type specificity in its extracellular portion. Langerin is unique among the CLRs in that it contains an intracellular domain with a proline-rich motif. Langerin expression has not been reported outside the DC system. (Valladeau J et al, 1999, Eur.J.Immunol., 29:2695-2704; Valladeau J et al, 2000 Immunity, 12 : 71-81; Kashihara M et al, 1986, J.Invest.Derm., 87 :602-607 Ito T et al, 1999, J.Immunol., 163 :1409-1419 ;Saeland S & Valladeau J, CD207 (Langerin) Workshop reports 2002, Leukocyte-Typing VII, White Cell Diff Antigens, D. Mason et al, Eds, Oxford University Press:306-307) |
) Anti-CD207 antibody (Alexa-fluor 546) |
|
STJ170015 |
St John's Laboratory |
100 µg |
EUR 393 |
|
Description: Langerin/CD207 is a transmembrane C-type lectin receptor (CLR) of epidermal and mucosal Langerhans cells (LCs) that induces Birbeck's granule formation. Langerin features a single carbohydrate recognition domain (CRD) with mannose-type specificity in its extracellular portion. Langerin is unique among the CLRs in that it contains an intracellular domain with a proline-rich motif. Langerin expression has not been reported outside the DC system. (Valladeau J et al, 1999, Eur.J.Immunol., 29:2695-2704; Valladeau J et al, 2000 Immunity, 12 : 71-81; Kashihara M et al, 1986, J.Invest.Derm., 87 :602-607 Ito T et al, 1999, J.Immunol., 163 :1409-1419 ;Saeland S & Valladeau J, CD207 (Langerin) Workshop reports 2002, Leukocyte-Typing VII, White Cell Diff Antigens, D. Mason et al, Eds, Oxford University Press:306-307) |
) Anti-CD207 antibody (Alexa-fluor 647) |
|
STJ170016 |
St John's Laboratory |
100 µg |
EUR 393 |
|
Description: Langerin/CD207 is a transmembrane C-type lectin receptor (CLR) of epidermal and mucosal Langerhans cells (LCs) that induces Birbeck's granule formation. Langerin features a single carbohydrate recognition domain (CRD) with mannose-type specificity in its extracellular portion. Langerin is unique among the CLRs in that it contains an intracellular domain with a proline-rich motif. Langerin expression has not been reported outside the DC system. (Valladeau J et al, 1999, Eur.J.Immunol., 29:2695-2704; Valladeau J et al, 2000 Immunity, 12 : 71-81; Kashihara M et al, 1986, J.Invest.Derm., 87 :602-607 Ito T et al, 1999, J.Immunol., 163 :1409-1419 ;Saeland S & Valladeau J, CD207 (Langerin) Workshop reports 2002, Leukocyte-Typing VII, White Cell Diff Antigens, D. Mason et al, Eds, Oxford University Press:306-307) |
) Anti-IL7R antibody (Alexa-fluor 488) |
|
STJ170020 |
St John's Laboratory |
100 µg |
EUR 393 |
|
Description: The IL7-R consists of 2 chains, IL-7R known as CD127 and common cytokine receptor chain known as CD132. A 75 to 80kDa human IL-7 receptor has been cloned that belongs to hematopoietic cytokinereceptor super family. R34-34, raised against human leukemic pre-B cells, recognized a molecule expressed on normal B cell precursors but not on mature B cells. This antibody specifically reverted IL-7 mediated growth inhibition of leukemic BCP (normal B cells precursors) and mature T cells. IL-7R expression is dramatically influenced by cytokines and antigens. This IL-7R displays both high and low affinity for its ligand (IL-7). Inhibitory and proliferative effects of IL-7 can be mediated through the same receptor on various lineages. CD4+ memory T cells express high level of IL-7R Subsets that express it generally require it, including progenitors of T and B cells, naïve and memory T cells. (Pandrau-Garcia D et al, 1994, Blood, 83, 3613-9 Mazzucchelli R et al, Nat. Review Immunol., 2007,7, 144-54) |
) Anti-IL7R antibody (Alexa-fluor 546) |
|
STJ170021 |
St John's Laboratory |
100 µg |
EUR 393 |
|
Description: The IL7-R consists of 2 chains, IL-7R known as CD127 and common cytokine receptor chain known as CD132. A 75 to 80kDa human IL-7 receptor has been cloned that belongs to hematopoietic cytokinereceptor super family. R34-34, raised against human leukemic pre-B cells, recognized a molecule expressed on normal B cell precursors but not on mature B cells. This antibody specifically reverted IL-7 mediated growth inhibition of leukemic BCP (normal B cells precursors) and mature T cells. IL-7R expression is dramatically influenced by cytokines and antigens. This IL-7R displays both high and low affinity for its ligand (IL-7). Inhibitory and proliferative effects of IL-7 can be mediated through the same receptor on various lineages. CD4+ memory T cells express high level of IL-7R Subsets that express it generally require it, including progenitors of T and B cells, naïve and memory T cells. (Pandrau-Garcia D et al, 1994, Blood, 83, 3613-9 Mazzucchelli R et al, Nat. Review Immunol., 2007,7, 144-54) |
) Anti-IL7R antibody (Alexa-fluor 647) |
|
STJ170022 |
St John's Laboratory |
100 µg |
EUR 393 |
|
Description: The IL7-R consists of 2 chains, IL-7R known as CD127 and common cytokine receptor chain known as CD132. A 75 to 80kDa human IL-7 receptor has been cloned that belongs to hematopoietic cytokinereceptor super family. R34-34, raised against human leukemic pre-B cells, recognized a molecule expressed on normal B cell precursors but not on mature B cells. This antibody specifically reverted IL-7 mediated growth inhibition of leukemic BCP (normal B cells precursors) and mature T cells. IL-7R expression is dramatically influenced by cytokines and antigens. This IL-7R displays both high and low affinity for its ligand (IL-7). Inhibitory and proliferative effects of IL-7 can be mediated through the same receptor on various lineages. CD4+ memory T cells express high level of IL-7R Subsets that express it generally require it, including progenitors of T and B cells, naïve and memory T cells. (Pandrau-Garcia D et al, 1994, Blood, 83, 3613-9 Mazzucchelli R et al, Nat. Review Immunol., 2007,7, 144-54) |
 Anti-RPSA Alexa Fluor® 488 |
|
A4-829-C100 |
ExBio |
0.1 mg |
EUR 310 |
 Anti-Hu CD16 Alexa Fluor® 488 |
|
A4-646-T100 |
ExBio |
100 tests |
EUR 269 |
 Alpha Fluor™ 594 C5 Maleimide |
|
1891 |
AAT Bioquest |
1 mg |
EUR 219 |
|
|
 conjugate) Streptavidin-Alexa594 (Alexas fluor 594) conjugate |
|
SV-A594-100 |
Alpha Diagnostics |
100 tests |
EUR 225 |
-Alexa 594 Fluor conjugate (adsorbed with human IgG)) Rabbit Anti-Rat IgG (H+L)-Alexa 594 Fluor conjugate (adsorbed with human IgG) |
|
50337 |
Alpha Diagnostics |
0.5 ml |
EUR 225 |
 Alpha Fluor™ 532 acid [equivalent to Alexa Fluor™ 532 acid] |
|
1795 |
AAT Bioquest |
10 mg |
EUR 393 |
|
|
 AF350-streptavidin conjugate [Streptavidin, Alexa Fluor™ 350 Conjugate] |
|
16890 |
AAT Bioquest |
1 mg |
EUR 176 |
|
|
 AF488-streptavidin conjugate [Streptavidin, Alexa Fluor™ 488 Conjugate] |
|
16891 |
AAT Bioquest |
1 mg |
EUR 176 |
|
|
 AF350 Phalloidin [equivalent to Alexa Fluor® 350 phalloidin] |
|
23150 |
AAT Bioquest |
300 Tests |
EUR 306 |
|
|
 AF488 Phalloidin [equivalent to Alexa Fluor® 488 phalloidin] |
|
23153 |
AAT Bioquest |
300 Tests |
EUR 306 |
|
|
 Anti-Hu CD72 Alexa Fluor® 488 |
|
A4-310-T100 |
ExBio |
100 tests |
EUR 269 |
 Anti-Bov CD9 Alexa Fluor® 488 |
|
A4-354-C100 |
ExBio |
0.1 mg |
EUR 269 |
 Anti-Hu CD30 Alexa Fluor® 700 |
|
A7-455-T100 |
ExBio |
100 tests |
EUR 269 |
 Anti-Hu CD94 Alexa Fluor® 700 |
|
A7-727-T100 |
ExBio |
100 tests |
EUR 269 |
 Anti-Hu CD56 Alexa Fluor® 700 |
|
A7-789-T100 |
ExBio |
100 tests |
EUR 269 |
 Alexa Fluor 647–conjugated) Goat Anti-Rabbit IgG(H+L) Alexa Fluor 647–conjugated |
|
S0013 |
Affbiotech |
200ul |
EUR 304 |
 Alexa Fluor 647–conjugated) Goat Anti-Mouse IgG(H+L) Alexa Fluor 647–conjugated |
|
S0014 |
Affbiotech |
200ul |
EUR 304 |
 Alexa Fluor 488–conjugated) Goat Anti-Mouse IgG(H+L) Alexa Fluor 488–conjugated |
|
S0017 |
Affbiotech |
200ul |
EUR 304 |
 Alexa Fluor 488–conjugated) Goat Anti-Rabbit IgG(H+L) Alexa Fluor 488–conjugated |
|
S0018 |
Affbiotech |
200ul |
EUR 304 |
, Alexa Fluor® 488 Conjugated) Donkey Anti-Rabbit IgG (H+L), Alexa Fluor® 488 Conjugated |
|
Ab8032-001 |
GenDepot |
0.5mg |
EUR 435 |
 Alexa Fluor<sup>®</sup> 488) Anti-Hu CD3 zeta (pY153) Alexa Fluor® 488 |
|
A4-686-C100 |
ExBio |
0.1 mg |
EUR 269 |
 Alexa Fluor<sup>®</sup> 488) Anti-Hu CD3 zeta (pY72) Alexa Fluor® 488 |
|
A4-712-C100 |
ExBio |
0.1 mg |
EUR 269 |
 Alexa Fluor<sup>®</sup> 488) Anti-Hu CD3 zeta (pY142) Alexa Fluor® 488 |
|
A4-730-C100 |
ExBio |
0.1 mg |
EUR 269 |
 Alexa Fluor<sup>®</sup> 488) Anti-Hu CD3 zeta (pY111) Alexa Fluor® 488 |
|
A4-737-C100 |
ExBio |
0.1 mg |
EUR 269 |
 Alexa Fluor<sup>®</sup> 647) Anti-Hu CD3 zeta (pY153) Alexa Fluor® 647 |
|
A6-686-C100 |
ExBio |
0.1 mg |
EUR 269 |
 Alexa Fluor<sup>®</sup> 647) Anti-Hu CD3 zeta (pY72) Alexa Fluor® 647 |
|
A6-712-C100 |
ExBio |
0.1 mg |
EUR 269 |
 Alexa Fluor<sup>®</sup> 647) Anti-Hu CD3 zeta (pY142) Alexa Fluor® 647 |
|
A6-730-C100 |
ExBio |
0.1 mg |
EUR 269 |
 Alexa Fluor<sup>®</sup> 647) Anti-Hu CD3 zeta (pY111) Alexa Fluor® 647 |
|
A6-737-C100 |
ExBio |
0.1 mg |
EUR 269 |
 Monoclonal Antibody (104G4) (Alexa Fluor<sup>®</sup> 488)) Anti-LAMP3 (human) Monoclonal Antibody (104G4) (Alexa Fluor® 488) |
|
M09406 |
BosterBio |
100ug |
EUR 565 |
|
Description: Mouse Monoclonal LAMP3 (human) Antibody (104G4) (Alexa Fluor® 488). Validated in IHC and tested in Human. |
 Monoclonal Antibody (DCGM4/122D5) (Alexa Fluor<sup>®</sup> 488)) Anti-Langerin (human) Monoclonal Antibody (DCGM4/122D5) (Alexa Fluor® 488) |
|
M02316 |
BosterBio |
100ug |
EUR 580 |
|
Description: Mouse Monoclonal Langerin (human) Antibody (DCGM4/122D5) (Alexa Fluor® 488). Validated in IHC and tested in Human. |
-Alexa 488 Fluor conjugate (adsorbed with human IgG)) Rabbit Anti-Rat IgG (H+L)-Alexa 488 Fluor conjugate (adsorbed with human IgG) |
|
50336 |
Alpha Diagnostics |
0.5 ml |
EUR 225 |
 Anti-Cytokeratins Alexa Fluor488 |
|
A4-108-C025 |
ExBio |
0.025 mg |
EUR 175 |
Anti-Cytokeratins Alexa Fluor488 |
|
A4-108-C100 |
ExBio |
0.1 mg |
EUR 310 |
 Anti-PSMA Alexa Fluor488 |
|
A4-539-C025 |
ExBio |
0.025 mg |
EUR 227 |
Anti-PSMA Alexa Fluor488 |
|
A4-539-C100 |
ExBio |
0.1 mg |
EUR 414 |
 Anti-FoxP3 Alexa Fluor488 |
|
A4-601-C025 |
ExBio |
0.025 mg |
EUR 201 |
Anti-FoxP3 Alexa Fluor488 |
|
A4-601-C100 |
ExBio |
0.1 mg |
EUR 362 |
 Anti-Phosphotyrosine Alexa Fluor647 |
|
A6-263-C025 |
ExBio |
0.025 mg |
EUR 154 |
Anti-Phosphotyrosine Alexa Fluor647 |
|
A6-263-C100 |
ExBio |
0.1 mg |
EUR 269 |
 Anti-LCK Alexa Fluor647 |
|
A6-269-C025 |
ExBio |
0.025 mg |
EUR 206 |
Anti-LCK Alexa Fluor647 |
|
A6-269-C100 |
ExBio |
0.1 mg |
EUR 373 |
 Anti-FoxP3 Alexa Fluor647 |
|
A6-601-C025 |
ExBio |
0.025 mg |
EUR 201 |
Anti-FoxP3 Alexa Fluor647 |
|
A6-601-C100 |
ExBio |
0.1 mg |
EUR 362 |
 Alpha Fluor™ 488 Hydroxylamine |
|
1900 |
AAT Bioquest |
1 mg |
EUR 306 |
|
|
 Tide Fluor 2-LL-37 |
|
H-8286.0100 |
Bachem |
0.1mg |
EUR 312 |
|
Description: Sum Formula: C205H340N60O53+dye |
Tide Fluor 2-LL-37 |
|
H-8286.0500 |
Bachem |
0.5mg |
EUR 1017 |
|
Description: Sum Formula: C205H340N60O53+dye |
 Helix Fluor™ 6-JOE Phosphoramidite |
|
6046 |
AAT Bioquest |
100 umoles |
EUR 50 |
|
|
 conjugate) Streptavidin-Alexa488 (Alexas fluor 488) conjugate |
|
SV-A488-100 |
Alpha Diagnostics |
100 tests |
EUR 225 |
) Tide Fluor 2-LL-37 (scrambled) |
|
H-8288.0100 |
Bachem |
0.1mg |
EUR 312 |
|
Description: Sum Formula: C205H340N60O53+dye |
Tide Fluor 2-LL-37 (scrambled) |
|
H-8288.0500 |
Bachem |
0.5mg |
EUR 1017 |
|
Description: Sum Formula: C205H340N60O53+dye |
 Tide Fluor 5WS-o-Conotoxin GVIA |
|
H-8356.0100 |
Bachem |
0.1mg |
EUR 1146 |
|
Description: Sum Formula: C120H182N38O43S6+dye |
 Anti-Cytokeratin 18 Alexa Fluor488 |
|
A4-106-C025 |
ExBio |
0.025 mg |
EUR 186 |
Anti-Cytokeratin 18 Alexa Fluor488 |
|
A4-106-C100 |
ExBio |
0.1 mg |
EUR 331 |
 Anti-Cytokeratin 19 Alexa Fluor488 |
|
A4-120-C025 |
ExBio |
0.025 mg |
EUR 186 |
Anti-Cytokeratin 19 Alexa Fluor488 |
|
A4-120-C100 |
ExBio |
0.1 mg |
EUR 331 |
 Anti-Ki-67 Alexa Fluor488 |
|
A4-155-T025 |
ExBio |
25 tests |
EUR 154 |
Anti-Ki-67 Alexa Fluor488 |
|
A4-155-T100 |
ExBio |
100 tests |
EUR 269 |
 Anti-Hu CD45 Alexa Fluor488 |
|
A4-160-T100 |
ExBio |
100 tests |
EUR 269 |
 Anti-Hu CD193 Alexa Fluor488 |
|
A4-161-T100 |
ExBio |
100 tests |
EUR 269 |
 Anti-Hu CD279 Alexa Fluor488 |
|
A4-176-T100 |
ExBio |
100 tests |
EUR 269 |
 Anti-Hu CD43 Alexa Fluor488 |
|
A4-220-T025 |
ExBio |
25 tests |
EUR 154 |
Anti-Hu CD43 Alexa Fluor488 |
|
A4-220-T100 |
ExBio |
100 tests |
EUR 269 |
 Anti-Hu CD44 Alexa Fluor488 |
|
A4-221-T025 |
ExBio |
25 tests |
EUR 154 |
Anti-Hu CD44 Alexa Fluor488 |
|
A4-221-T100 |
ExBio |
100 tests |
EUR 269 |
Anti-Hu CD45 Alexa Fluor488 |
|
A4-222-T025 |
ExBio |
25 tests |
EUR 154 |
Anti-Hu CD45 Alexa Fluor488 |
|
A4-222-T100 |
ExBio |
100 tests |
EUR 269 |
 Anti-Hu CD55 Alexa Fluor488 |
|
A4-230-T025 |
ExBio |
25 tests |
EUR 154 |
Anti-Hu CD55 Alexa Fluor488 |
|
A4-230-T100 |
ExBio |
100 tests |
EUR 269 |
 Anti-Hu CD50 Alexa Fluor488 |
|
A4-266-T025 |
ExBio |
25 tests |
EUR 154 |
Anti-Hu CD50 Alexa Fluor488 |
|
A4-266-T100 |
ExBio |
100 tests |
EUR 269 |
 Anti-Hu CD31 Alexa Fluor488 |
|
A4-273-T025 |
ExBio |
25 tests |
EUR 154 |
Anti-Hu CD31 Alexa Fluor488 |
|
A4-273-T100 |
ExBio |
100 tests |
EUR 269 |
Most gadgets functioned significantly properly at low and reasonable ranges of the assemble, however just a few had been in a position to seize increased ranges of the assemble. Based on our IRT analyses of the efficiency of gadgets on the subscales, we chosen gadgets to create a quick model of the SPCS-Y (BSPCS-Y) and carried out structural equation modeling for additional examination. Results present empirical proof to assist the reliability and validity of the SPCS-Y and recommend a quick model based mostly on high-performing gadgets is feasible.
 Human Thyrostimulin Beta)
